EFFIE W PETERSDORF, MD
Osteopathic Medicine at Eastlake Ave, Seattle, WA

License number
Washington MD00020961
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
825 Eastlake Ave E, Seattle, WA 98109
Phone
(206) 288-1000
(206) 543-6420

Personal information

See more information about EFFIE W PETERSDORF at radaris.com
Name
Address
Phone
Effie W Petersdorf, age 67
3716 47Th Pl NE, Seattle, WA 98105
(206) 522-9089
Effie W Petersdorf, age 67
3716 47Th St, Seattle, WA 98105
(206) 522-9089
Effie W Petersdorf, age 74
7301 50Th Ave NE, Seattle, WA 98115
(206) 522-9089
Effie W Petersdorf, age 74
7301 50Th St, Seattle, WA 98115
(206) 522-9089

Professional information

Effie Wang Petersdorf Photo 1

Effie Wang Petersdorf, Seattle WA

Specialties:
Internal Medicine, Hematology & Oncology, Medical Oncology
Work:
Seattle Cancer Alliance Outpatient Ambulatory
825 Eastlake Ave E, Seattle, WA 98109 Seattle Cancer Care Alliance - Inpatient at Uwmc
1959 Ne Pacific St, Seattle, WA 98195
Education:
McGill University Faculty Of Medicine (1982)


Effie W Petersdorf Photo 2

Dr. Effie W Petersdorf, Seattle WA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
825 Eastlake Ave E, Seattle 98109
(206) 288-1000 (Phone), (206) 288-1025 (Fax)
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 Fairview Ave N, Seattle 98109
(206) 667-5000 (Phone), (206) 667-5268 (Fax)
Languages:
English
Hospitals:
825 Eastlake Ave E, Seattle 98109
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 Fairview Ave N, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
McGill University Faculty Of Medicine


Effie E Petersdorf Photo 3

Effie E Petersdorf, Seattle WA

Specialties:
Oncologist
Address:
1100 Fairview Ave N, Seattle, WA 98109
825 Eastlake Ave E, Seattle, WA 98109


Effie Petersdorf Photo 4

Methods For Haplotyping Genomic Dna

US Patent:
7972791, Jul 5, 2011
Filed:
Sep 29, 2009
Appl. No.:
12/569044
Inventors:
Effie W. Petersdorf - Seattle WA, US
Zhen Guo - Bellevue WA, US
Leroy Hood - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
Institute for Systems Biology - Seattle WA
International Classification:
C12Q 1/68, C07H 21/02, C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
The present invention provides a novel method for specifically isolating and separating large segments of genomic DNA that can subsequently be used to determine a genomic haplotype. The invention relies on using a solid phase having a flat surface arrayed with oligonucleotides designed to specifically hybridize to each particular haplotype of an individual sample, e. g. , oligonucleotides designed to specifically hybridize with each of the two HLA-B haplotypes, HLA-A, HLA-C, HLA-DR, HLA-DQ, and the like. The genomic DNA is contacted and hybridized to the arrayed oligonucleotides to form a genomic DNA/oligonucleotide complex. The excess genomic DNA is washed away and the haplotype separated genomic DNA is denatured from the oligonucleotide probe and collected. The method of the present invention allows for the separation of genomic DNA fragments of between approximately 2 to about 4 megabases (Mb). Separation of the haplotypes of large genomic DNA fragments allows for linkage analysis of other HLA alleles and polymorphisms, microsatellite, SNPs, and the like across a large span of the HLA region, including HLA-A, -B, -C, and HLA-DRB1 regions.


Effie Petersdorf Photo 5

Methods For Haplotyping Genomic Dna

US Patent:
7615350, Nov 10, 2009
Filed:
Oct 19, 2007
Appl. No.:
11/874407
Inventors:
Effie W. Petersdorf - Seattle WA, US
Zhen Guo - Bellevue WA, US
Leroy Hood - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
Institute for Systems Biology - Seattle WA
International Classification:
C12Q 1/68, C07H 21/02, C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
The present invention provides a novel method for specifically isolating and separating large segments of genomic DNA that can subsequently be used to determine a genomic haplotype. The invention relies on using a solid phase having a flat surface arrayed with oligonucleotides designed to specifically hybridize to each particular haplotype of an individual sample, e. g. , oligonucleotides designed to specifically hybridize with each of the two HLA-B haplotypes, HLA-A, HLA-C, HLA-DR, HLA-DQ, and the like. The genomic DNA is contacted and hybridized to the arrayed oligonucleotides to form a genomic DNA/oligonucleotide complex. The excess genomic DNA is washed away and the haplotype separated genomic DNA is denatured from the oligonucleotide probe and collected. The method of the present invention allows for the separation of genomic DNA fragments of between approximately 2 to about 4 megabases (Mb). Separation of the haplotypes of large genomic DNA fragments allows for linkage analysis of other HLA alleles and polymorphisms, microsatellite, SNPs, and the like across a large span of the HLA region, including HLA-A, -B, -C, and HLA-DRB1 regions.


Effie Petersdorf Photo 6

Methods For Haplotyping Genomic Dna

US Patent:
7300755, Nov 27, 2007
Filed:
May 12, 2004
Appl. No.:
10/843985
Inventors:
Effie W. Petersdorf - Seattle WA, US
Zhen Guo - Bellevue WA, US
Leroy Hood - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
Institute for Systems Biology - Seattle WA
International Classification:
C12Q 1/68, C07H 21/02, C07H 21/04
US Classification:
435 6, 536 231, 536 243
Abstract:
The present invention provides a novel method for specifically isolating and separating large segments of genomic DNA that can subsequently be used to determine a genomic haplotype. The invention relies on using a solid phase having a flat surface arrayed with oligonucleotides designed to specifically hybridize to each particular haplotype of an individual sample, e. g. , oligonucleotides designed to specifically hybridize with each of the two HLA-B haplotypes, HLA-A, HLA-C, HLA-DR, HLA-DQ, and the like. The genomic DNA is contacted and hybridized to the arrayed oligonucleotides to form a genomic DNA/oligonucleotide complex. The excess genomic DNA is washed away and the haplotype separated genomic DNA is denatured from the oligonucleotide probe and collected. The method of the present invention allows for the separation of genomic DNA fragments of between approximately 2 to about 4 megabases (Mb). Separation of the haplotypes of large genomic DNA fragments allows for linkage analysis of other HLA alleles and polymorphisms, microsatellite, SNPs, and the like across a large span of the HLA region, including HLA-A, -B, -C, and HLA-DRB1 regions.


Effie Petersdorf Photo 7

Oligonucleotide Arrays For High Resolution Hla Typing

US Patent:
2009009, Apr 16, 2009
Filed:
Nov 25, 2008
Appl. No.:
12/277511
Inventors:
Effie W. Petersdorf - Seattle WA, US
Zhen Guo - Bellevue WA, US
John A. Hansen - Mercer Island WA, US
Leroy Hood - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
The University of Washington - Seattle WA
International Classification:
C40B 30/04, C40B 40/08, C40B 50/18
US Classification:
506 9, 506 17, 506 32
Abstract:
Arrays of HLA Class I oligonucleotide probes on a solid support are provided, wherein the probes are sufficient to represent at least 80% of the known polymorphisms in exons 2 and 3 of the HLA Class I locus.


Effie Petersdorf Photo 8

Oligonucleotide Arrays For High Resolution Hla Typing

US Patent:
2008018, Aug 7, 2008
Filed:
Sep 7, 2006
Appl. No.:
11/517956
Inventors:
Effie W. Petersdorf - Seattle WA, US
Zhen Guo - Bellevue WA, US
John A. Hansen - Mercer Island WA, US
Leroy Hood - Seattle WA, US
Assignee:
Fred Hutchinson Cancer Research Center - Seattle WA
The University of Washington Office of Technology Transfer - Seattle WA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Arrays of HLA Class I oligonucleotide probes on a solid support are provided, wherein the probes are sufficient to represent at least 80% of the known polymorphisms in exons 2 and 3 of the HLA Class I locus.